<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H88CC16FA18714EA990FD675BAE0D9C8F" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>118 HR 1768 IH: NIH Reform Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2023-03-23</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">118th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 1768</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20230323">March 23, 2023</action-date><action-desc><sponsor name-id="R000614">Mr. Roy</sponsor> (for himself, <cosponsor name-id="M001211">Mrs. Miller of Illinois</cosponsor>, <cosponsor name-id="G000565">Mr. Gosar</cosponsor>, <cosponsor name-id="J000304">Mr. Jackson of Texas</cosponsor>, <cosponsor name-id="H001096">Ms. Hageman</cosponsor>, <cosponsor name-id="B000825">Mrs. Boebert</cosponsor>, <cosponsor name-id="B001302">Mr. Biggs</cosponsor>, <cosponsor name-id="B001316">Mr. Burlison</cosponsor>, <cosponsor name-id="R000103">Mr. Rosendale</cosponsor>, <cosponsor name-id="B001317">Mr. Brecheen</cosponsor>, <cosponsor name-id="L000596">Mrs. Luna</cosponsor>, <cosponsor name-id="B001311">Mr. Bishop of North Carolina</cosponsor>, <cosponsor name-id="G000578">Mr. Gaetz</cosponsor>, <cosponsor name-id="S001214">Mr. Steube</cosponsor>, <cosponsor name-id="G000589">Mr. Gooden of Texas</cosponsor>, and <cosponsor name-id="G000595">Mr. Good of Virginia</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To replace the National Institute of Allergy and Infectious Diseases with 3 separate national research institutes.</official-title></form><legis-body id="H3568D429D8224176ADBA74CB9D778904" style="OLC"> 
<section id="HC7B6855C18F348C5B3FB25F547D50FD8" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>NIH Reform Act</short-title></quote>.</text></section> <section commented="no" display-inline="no-display-inline" id="HF1044919AC01456C9896042B6E6157A6" section-type="subsequent-section"><enum>2.</enum><header display-inline="yes-display-inline">Division of National Institute of Allergy and Infectious Diseases</header> <subsection id="H3DBF4D60701B46D6827BB932EA4EE95C"><enum>(a)</enum><header>Organization of national research institutes</header><text>Section 401 of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/281">42 U.S.C. 281</external-xref>) is amended—</text> 
<paragraph id="H48A3718B1BFA4EBB9870E5C8D673DBD9"><enum>(1)</enum><text>in subsection (b)—</text> <subparagraph id="HAC728419C20848519564402C4B79A78A"><enum>(A)</enum><text>in paragraph (6), by striking <quote>Allergy and Infectious Diseases</quote> and inserting <quote>Allergic Diseases</quote>;</text></subparagraph> 
<subparagraph id="HE432A4BDDDB14EF09874F483A8F3EAF3"><enum>(B)</enum><text>by redesignating paragraph (25) as paragraph (27); and</text></subparagraph> <subparagraph id="H5DDBEF08A4D847F98F30ED64111C2DE3"><enum>(C)</enum><text>by inserting after paragraph (24) the following:</text> 
<quoted-block style="OLC" display-inline="no-display-inline" id="H7EDC9C4022354F788570F43293C89049"> 
<paragraph id="HEE0BB358052E488EB1CD4AF9A09AC22D"><enum>(25)</enum><text>The National Institute of Infectious Diseases.</text></paragraph> <paragraph id="H83A8F523CBAA4334BDF28CA07B945072"><enum>(26)</enum><text>The National Institute of Immunologic Diseases.</text></paragraph><after-quoted-block>; and</after-quoted-block></quoted-block></subparagraph></paragraph> 
<paragraph id="H2A42F899143B491BBCFD773615804856"><enum>(2)</enum><text>in subsection (d)(1), by striking <quote>27</quote> and inserting <quote>29</quote>.</text></paragraph></subsection> <subsection id="HD245B4D36CDC48A799CEE42E2ADD9512"><enum>(b)</enum><header>Appointment of directors</header> <paragraph id="HB7C5BC38E11E4E24BF265BE2B9EBB7F7"><enum>(1)</enum><header>In general</header><text>Section 405(a)(1) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/284">42 U.S.C. 284(a)(1)</external-xref>) is amended—</text> 
<subparagraph id="H9CDD1FECDAFA4753BB9E2D49A668FEB0"><enum>(A)</enum><text>by inserting <quote>, the Director of the National Institute of Allergic Diseases, the Director of the National Institute of Infectious Diseases, and the Director of the National Institute of Immunologic Diseases</quote> after <quote>National Cancer Institute</quote>; and</text></subparagraph> <subparagraph id="HC852A28DED714E76A63EC23811CD2BEE"><enum>(B)</enum><text>by inserting <quote>by and with the advice and consent of the Senate,</quote> after <quote>the President,</quote>.</text></subparagraph></paragraph> 
<paragraph id="H6C8D7D9D7FDF4DC4876D125E94B50F55"><enum>(2)</enum><header>Terms</header><text>Section 405(a) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/284">42 U.S.C. 284(a)</external-xref>) is amended by adding at the end the following:</text> <quoted-block style="OLC" display-inline="no-display-inline" id="HEDAC8135CEE9473C9CB9C56F9608C39A"> <paragraph id="H569462191AA24598A5DF6760E08902B3"><enum>(4)</enum><header>Certain appointments by the President</header><text>The appointments by the President of the Director of the National Institute of Allergic Diseases, the Director of the National Institute of Infectious Diseases, and the Director of the National Institute of Immunologic Diseases shall be for terms of 5 years. Each such Director may be reappointed for not more than 1 additional term, in accordance paragraph (1).</text></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></paragraph> 
<paragraph id="HCBA58CFA800A435A9C3949C4E610BADB"><enum>(3)</enum><header>Transition</header><text>Effective on the date of enactment of this Act, the position of Director of the National Institute of Allergy and Infectious Diseases is terminated, and the National Institute of Allergic Diseases, the National Institute of Infectious Diseases, and the National Institute of Immunologic Diseases shall be overseen by the Director of the National Institutes of Health until such time as the directors of each such national institutes is appointed pursuant to section 405(a)(1) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/284">42 U.S.C. 284(a)(1)</external-xref>), as amended by paragraph (1).</text></paragraph></subsection> <subsection id="HDE211548FF204AECB362857B3A6F7577"><enum>(c)</enum><header>Duties of the National Institutes</header> <paragraph id="H81860FBBF65F41DB92BAF59D81206A01"><enum>(1)</enum><header>National Institute of Allergic Diseases</header><text>Subpart 6 of part C of title IV of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/285f">42 U.S.C. 285f et seq.</external-xref>) is amended—</text> 
<subparagraph id="H388DE0E75A16402C993747C985E92BF8"><enum>(A)</enum><text>in the subpart heading, by striking <quote><header-in-text style="OLC" level="subpart">Allergy and infectious diseases</header-in-text></quote> and inserting <quote><header-in-text style="OLC" level="subpart">Allergic Diseases</header-in-text></quote>; and</text></subparagraph> <subparagraph id="H88CB986DBCB64F5DA71B0C2BFD2E3B1A"><enum>(B)</enum><text>in section 446—</text> 
<clause id="H1FEE375C9A4546A9924E433462A93E6B"><enum>(i)</enum><text>by striking <quote>Allergy and Infectious Diseases</quote> and inserting <quote>Allergic Diseases</quote>; and</text></clause> <clause id="H0ED49E7906A4474CA4253E41B45BA962"><enum>(ii)</enum><text>by striking <quote>allergic and immunologic diseases and disorders and infectious diseases, including tropical diseases</quote> and inserting <quote>allergic diseases and disorders</quote>.</text></clause></subparagraph></paragraph> 
<paragraph id="HEE558A7E1C1C4942A9DBE7873282D971"><enum>(2)</enum><header>National Institute of Infectious Diseases</header> 
<subparagraph id="HA060D315EB8F43B9BEDE5DB212046BAB"><enum>(A)</enum><header>In general</header><text>Part C of title IV of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/285">42 U.S.C. 285 et seq.</external-xref>) is amended by adding at the end the following:</text> <quoted-block style="OLC" display-inline="no-display-inline" id="H8EA91BB6E5544E20A9558EB63B20E053"> <subpart id="H3F9390A5565341A3A88B73E6B22DE3A3" style="OLC"><enum>21</enum><header>National Institute of Infectious Diseases</header> <section id="H33094D8D62D84CCA8F73ACD9615B677A"><enum>464z–10.</enum><header>Purpose of the Institute</header><text display-inline="no-display-inline">The general purpose of the National Institute of Infectious Diseases is the conduct and support of research, training, health information dissemination, and other programs with respect to infectious diseases, including tropical diseases.</text></section></subpart><after-quoted-block>.</after-quoted-block></quoted-block></subparagraph> 
<subparagraph id="HE5FD46065F194D72A13247B8363964E4"><enum>(B)</enum><header>Transfer of authorities</header><text>Sections 447A and 447B of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/285f-2">42 U.S.C. 285f–2</external-xref>; 285f–3) are—</text> <clause id="H237DAF67858E43E8A408E596F84C179C"><enum>(i)</enum><text>redesignated as sections 464z–11 and 464–12, respectively; and</text></clause> 
<clause id="H11FD9F52389647BAB570B2D37EE40179"><enum>(ii)</enum><text>transferred to appear after section 464z–10 of such Act, as added by subparagraph (A).</text></clause></subparagraph> <subparagraph id="H84FF5A4DDFE04D8980399BAA97187342"><enum>(C)</enum><header>Orderly transition</header><text>The Director of the National Institutes of Health shall take such steps as are necessary to provide for the orderly transition to the authority of the National Institute of Infectious Diseases established under section 464z–10 of the Public Health Service Act, as added by subparagraph (A), from any authority related to infectious diseases of the National Institute of Allergy and Infectious Diseases, as in effect on the day before the date of enactment of this Act. </text></subparagraph></paragraph> 
<paragraph id="H4BEA0D07EE30471F8178D8433E390487"><enum>(3)</enum><header>National Institute of Immunologic Diseases</header> 
<subparagraph id="H461DB866E4084E5787D08B42D6C0822B"><enum>(A)</enum><header>In general</header><text>Part C of title IV of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/285">42 U.S.C. 285 et seq.</external-xref>), as amended by paragraph (2), is further amended by adding at the end the following:</text> <quoted-block style="OLC" display-inline="no-display-inline" id="HA7DDD1F04A51410686769D7FE8DF3D70"> <subpart id="H6E9C4ED7501C4A50BE093C516389563E" style="OLC"><enum>22</enum><header>National Institute of Immunologic Diseases</header> <section id="H86EADE00B0244D87A05A9F00A285491F"><enum>464z–15.</enum><header>Purpose of the Institute</header><text display-inline="no-display-inline">The general purpose of the National Institute of Immunologic Diseases is the conduct and support of research, training, health information dissemination, and other programs with respect to immunologic diseases and disorders. </text></section></subpart><after-quoted-block>. </after-quoted-block></quoted-block></subparagraph> 
<subparagraph id="H45C1085EC8AC4D9EA4E8FD767BB040D8"><enum>(B)</enum><header>Transfer of authorities</header><text>Sections 447 and 447C of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/285f-1">42 U.S.C. 285f–1</external-xref>; 285f–4) are—</text> <clause id="H78CAB4C7E38E4327B51EB1B5420B063C"><enum>(i)</enum><text>redesignated as sections 464z–16 and 464z–17, respectively; and</text></clause> 
<clause id="HC7B90D4D676640A4BAA8A52DC563A55F"><enum>(ii)</enum><text>transferred to appear after section 464z–15 of such Act, as added by subparagraph (A).</text></clause></subparagraph> <subparagraph id="H41DCBBA638EB489898B1CCCB8677A759"><enum>(C)</enum><header>Orderly transition</header><text>The Director of the National Institutes of Health shall take such steps as are necessary to provide for the orderly transition to the authority of the National Institute of Immunologic Diseases established under section 464z–15 of the Public Health Service Act, as added by subparagraph (A), from any authority related to immunologic diseases and disorders of the National Institute of Allergy and Infectious Diseases, as in effect on the day before the date of enactment of this Act. </text></subparagraph></paragraph></subsection> 
<subsection id="H9E9CDF59601441DABD9A0A52E83BDFBD"><enum>(d)</enum><header>Conforming amendments</header> 
<paragraph id="H118D7D1CEC6141A69FE666893291C551"><enum>(1)</enum><text>Section 404B of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/283d">42 U.S.C. 283d</external-xref>) is amended by striking <quote>National Institute for Allergy and Infectious Diseases</quote> and inserting <quote>National Institute for Infectious Diseases</quote>.</text></paragraph> <paragraph id="HDF8D368F479242A99A0F019604D1AB57"><enum>(2)</enum><text>Section 404I of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/283k">42 U.S.C. 283k</external-xref>) is amended—</text> 
<subparagraph id="H0E374F97284C4872AF786E9FD66C4F19"><enum>(A)</enum><text>in subsection (a)(1), by striking <quote>or the Director of the National Institute for Allergy and Infectious Diseases</quote>; and</text></subparagraph> <subparagraph id="H7F9BD0F6F04147B99A8C5D6E93430FA7"><enum>(B</enum><text>by striking <quote>or the National Institute for Allergy and Infectious Diseases</quote> each place it appears.</text></subparagraph></paragraph> 
<paragraph id="H20E8EFEBD0EC4CC9AB16591D6B4E2BCB"><enum>(3)</enum><text>Section 442A(a) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/285d-8">42 U.S.C. 285d–8(a)</external-xref>) is amended by striking <quote>Allergy and Infectious Diseases</quote> and inserting <quote>Immunologic Diseases</quote>.</text></paragraph> <paragraph id="HB21D0B21EE804BEB88F22F7EF1694367"><enum>(4)</enum><text>Any reference in any law (including a regulation), guidance, map, document, record, or other paper of the United States to the National Institute of Allergy and Infectious Diseases, including with respect to the Director of such Institute, shall be deemed to be a reference to, as applicable, the National Institute of Allergic Diseases, the National Institute of Infectious Diseases, or the National Institute of Immunologic Diseases, including with respect to the Directors of such Institutes.</text></paragraph></subsection></section> 
</legis-body></bill>

